Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
Clinical trial NCT03821038 · TERMINATED
Trial details
- NCT number
- NCT03821038
- Sponsor
- Revimmune
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-01
- Primary completion
- 2021-10-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.